vs
Side-by-side financial comparison of Axil Brands, Inc. (AXIL) and Cytosorbents Corp (CTSO). Click either name above to swap in a different company.
Cytosorbents Corp is the larger business by last-quarter revenue ($9.2M vs $8.1M, roughly 1.1× Axil Brands, Inc.). Axil Brands, Inc. runs the higher net margin — 8.7% vs -59.5%, a 68.2% gap on every dollar of revenue. On growth, Axil Brands, Inc. posted the faster year-over-year revenue change (5.2% vs 0.9%). Axil Brands, Inc. produced more free cash flow last quarter ($906.4K vs $-4.9M). Over the past eight quarters, Axil Brands, Inc.'s revenue compounded faster (12.1% CAGR vs 1.3%).
Axil Brands, Inc. is a U.S.-headquartered company that designs, manufactures and markets premium hearing protection products, audio enhancement devices and personal audio accessories. Its offerings include custom-fit earplugs, Bluetooth-enabled hearing buds for work, sports and leisure use, serving both consumer and professional segments across global markets.
CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.
AXIL vs CTSO — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.1M | $9.2M |
| Net Profit | $704.9K | $-5.5M |
| Gross Margin | 68.1% | 73.7% |
| Operating Margin | 11.1% | -47.5% |
| Net Margin | 8.7% | -59.5% |
| Revenue YoY | 5.2% | 0.9% |
| Net Profit YoY | 11.2% | 27.4% |
| EPS (diluted) | $0.09 | $-0.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $8.1M | $9.2M | ||
| Q3 25 | $6.9M | $9.5M | ||
| Q2 25 | $5.8M | $9.6M | ||
| Q1 25 | $6.9M | $8.7M | ||
| Q4 24 | $7.7M | $9.2M | ||
| Q3 24 | $5.9M | $8.6M | ||
| Q2 24 | $6.5M | $8.8M | ||
| Q1 24 | $6.5M | $9.0M |
| Q4 25 | $704.9K | $-5.5M | ||
| Q3 25 | $334.3K | $-3.2M | ||
| Q2 25 | $-245.6K | $1.9M | ||
| Q1 25 | $576.7K | $-1.5M | ||
| Q4 24 | $633.7K | $-7.6M | ||
| Q3 24 | $-109.8K | $-2.8M | ||
| Q2 24 | $49.5K | $-4.3M | ||
| Q1 24 | $781.1K | $-6.1M |
| Q4 25 | 68.1% | 73.7% | ||
| Q3 25 | 67.6% | 70.3% | ||
| Q2 25 | 70.0% | 70.9% | ||
| Q1 25 | 71.7% | 71.1% | ||
| Q4 24 | 71.1% | 68.4% | ||
| Q3 24 | 71.0% | 61.0% | ||
| Q2 24 | 71.5% | 73.5% | ||
| Q1 24 | 71.5% | 76.5% |
| Q4 25 | 11.1% | -47.5% | ||
| Q3 25 | 6.0% | -30.2% | ||
| Q2 25 | 0.8% | -37.6% | ||
| Q1 25 | 8.4% | -44.5% | ||
| Q4 24 | 8.7% | -37.1% | ||
| Q3 24 | -2.4% | -56.1% | ||
| Q2 24 | 2.6% | -40.4% | ||
| Q1 24 | -1.6% | -51.8% |
| Q4 25 | 8.7% | -59.5% | ||
| Q3 25 | 4.9% | -33.4% | ||
| Q2 25 | -4.3% | 20.2% | ||
| Q1 25 | 8.3% | -16.9% | ||
| Q4 24 | 8.2% | -82.7% | ||
| Q3 24 | -1.9% | -32.1% | ||
| Q2 24 | 0.8% | -48.6% | ||
| Q1 24 | 12.1% | -67.7% |
| Q4 25 | $0.09 | $-0.09 | ||
| Q3 25 | $0.04 | $-0.05 | ||
| Q2 25 | $-0.03 | $0.03 | ||
| Q1 25 | $0.07 | $-0.02 | ||
| Q4 24 | $0.08 | $-0.14 | ||
| Q3 24 | $-0.02 | $-0.05 | ||
| Q2 24 | $0.11 | $-0.08 | ||
| Q1 24 | $0.04 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.0M | $6.2M |
| Total DebtLower is stronger | $138.3K | — |
| Stockholders' EquityBook value | $11.1M | $5.9M |
| Total Assets | $16.2M | $44.2M |
| Debt / EquityLower = less leverage | 0.01× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.0M | $6.2M | ||
| Q3 25 | $4.1M | $7.5M | ||
| Q2 25 | $4.8M | $10.2M | ||
| Q1 25 | $4.7M | $11.6M | ||
| Q4 24 | $5.2M | $3.3M | ||
| Q3 24 | $4.1M | $5.7M | ||
| Q2 24 | $3.3M | $8.5M | ||
| Q1 24 | $4.9M | $8.6M |
| Q4 25 | $138.3K | — | ||
| Q3 25 | $139.2K | — | ||
| Q2 25 | $140.2K | — | ||
| Q1 25 | $141.0K | — | ||
| Q4 24 | $143.3K | — | ||
| Q3 24 | $144.3K | $13.8M | ||
| Q2 24 | $146.6K | $13.7M | ||
| Q1 24 | — | $4.4M |
| Q4 25 | $11.1M | $5.9M | ||
| Q3 25 | $10.2M | $9.0M | ||
| Q2 25 | $9.7M | $11.6M | ||
| Q1 25 | $9.7M | $14.5M | ||
| Q4 24 | $8.8M | $11.1M | ||
| Q3 24 | $7.9M | $13.4M | ||
| Q2 24 | $7.7M | $17.4M | ||
| Q1 24 | $8.8M | $19.6M |
| Q4 25 | $16.2M | $44.2M | ||
| Q3 25 | $15.4M | $45.8M | ||
| Q2 25 | $12.9M | $48.0M | ||
| Q1 25 | $13.0M | $50.8M | ||
| Q4 24 | $13.7M | $47.4M | ||
| Q3 24 | $11.4M | $47.8M | ||
| Q2 24 | $11.0M | $53.4M | ||
| Q1 24 | $12.7M | $47.1M |
| Q4 25 | 0.01× | — | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 0.02× | — | ||
| Q3 24 | 0.02× | 1.03× | ||
| Q2 24 | 0.02× | 0.78× | ||
| Q1 24 | — | 0.23× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $934.8K | $-4.8M |
| Free Cash FlowOCF − Capex | $906.4K | $-4.9M |
| FCF MarginFCF / Revenue | 11.1% | -53.4% |
| Capex IntensityCapex / Revenue | 0.3% | 1.2% |
| Cash ConversionOCF / Net Profit | 1.33× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-12.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $934.8K | $-4.8M | ||
| Q3 25 | $-739.2K | $-2.6M | ||
| Q2 25 | $194.4K | $-1.5M | ||
| Q1 25 | $-169.9K | $-3.5M | ||
| Q4 24 | $1.0M | $-2.3M | ||
| Q3 24 | $897.3K | $-2.5M | ||
| Q2 24 | $-336.6K | $-4.8M | ||
| Q1 24 | $-912.8K | $-4.8M |
| Q4 25 | $906.4K | $-4.9M | ||
| Q3 25 | $-747.6K | $-2.6M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | $-258.2K | $-3.5M | ||
| Q4 24 | $941.1K | $-2.4M | ||
| Q3 24 | — | $-2.6M | ||
| Q2 24 | $-394.9K | $-4.8M | ||
| Q1 24 | $-922.1K | $-4.9M |
| Q4 25 | 11.1% | -53.4% | ||
| Q3 25 | -10.9% | -27.3% | ||
| Q2 25 | — | -16.1% | ||
| Q1 25 | -3.7% | -39.7% | ||
| Q4 24 | 12.2% | -26.3% | ||
| Q3 24 | — | -30.4% | ||
| Q2 24 | -6.1% | -54.4% | ||
| Q1 24 | -14.3% | -54.2% |
| Q4 25 | 0.3% | 1.2% | ||
| Q3 25 | 0.1% | 0.2% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | 1.3% | 0.0% | ||
| Q4 24 | 0.9% | 0.8% | ||
| Q3 24 | — | 1.8% | ||
| Q2 24 | 0.9% | 0.2% | ||
| Q1 24 | 0.1% | 0.5% |
| Q4 25 | 1.33× | — | ||
| Q3 25 | -2.21× | — | ||
| Q2 25 | — | -0.78× | ||
| Q1 25 | -0.29× | — | ||
| Q4 24 | 1.59× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -6.80× | — | ||
| Q1 24 | -1.17× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXIL
| Hearing Enhancement And Protection | $7.8M | 95% |
| Other | $378.9K | 5% |
CTSO
| Direct | $5.1M | 55% |
| Distributors And Strategic Partners | $4.2M | 45% |
